Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer
Lung cancer is the leading cause of deaths resulting from cancer owing to late diagnosis and limited treatment intervention. MicroRNAs are short, non-coding RNA molecules that regulate gene expression post-transcriptionally by translational repression or target messenger RNA degradation. Accumulatin...
Main Author: | Kentaro Inamura |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/9/5/49 |
Similar Items
-
Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification
by: Kentaro Inamura
Published: (2017-08-01) -
Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer
by: Kentaro Inamura
Published: (2017-05-01) -
Improved lung cancer classification by employing diverse molecular features of microRNAs
by: Shiyong Guo, et al.
Published: (2024-02-01) -
Harnessing Extracellular microRNAs for Diagnostics and Therapeutics in Acute Systemic Inflammation
by: Russell Hollis, et al.
Published: (2024-03-01) -
Smoking-related dysregulation of plasma circulating microRNAs: the Rotterdam study
by: Irma Karabegović, et al.
Published: (2023-07-01)